Discovery of a selective cytochrome P450 4A inhibitor for the treatment of metabolic dysfunction-associated fatty liver disease

Minji Lee; Myung Jin Son; Sin-Hyoung Hong; Jae-Sung Ryu; Ji-Hyeon Min; Dong-Eon Lee; Ji Hoon Lee; Nam Doo Kim; Shi-Young Park; Darong Kim; Jeongmin Joo; Jisung Kwak; Kook Hwan Kim; Yong-Ho Lee; Byeong-Rak Keum; Hyun Seok Song; Youngae Jung; Koon Soon Kim; Gun-Hwa Kim

doi:10.1002/ctm2.1816

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (10) : e1816 DOI: 10.1002/ctm2.1816

LETTER TO THE JOURNAL

Discovery of a selective cytochrome P450 4A inhibitor for the treatment of metabolic dysfunction-associated fatty liver disease

Author information +

¹. Digital Omics Research Center, Korea Basic Science Institute (KBSI), Cheongju, Republic of Korea

². Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea

³. Department of Functional Genomics, Korea University of Science & Technology (UST), Daejeon, Republic of Korea

⁴. School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea

⁵. New Drug Development Center, Osong Medical Innovation Foundation, Cheongju, Republic of Korea

⁶. Department of Analytical Science and Technology, Graduate School of Analytical Science and Technology (GRAST), Chungnam National University, Daejeon, Republic of Korea

⁷. Department of Bio-Analytical Science, University of Science and Technology (UST), Daejeon, Republic of Korea

⁸. New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea

⁹. New Drug Discovery & Development, VORONOIBIO Inc., Incheon, Republic of Korea

¹⁰. Korea Mouse Metabolic Phenotyping Center, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, South Korea

¹¹. Sensor System Research Center, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea

¹². Department of Chemical and Biological Engineering, Korea University, Seoul, Republic of Korea

¹³. Discovery Division, GI Innovation, Inc., Seoul, South Korea

¹⁴. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea

¹⁵. Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea

¹⁶. Integrated Metabolomics Research Group, Metropolitan Seoul Center, Korea Basic Science Institute (KBSI), Seoul, Republic of Korea

¹⁷. Division of Endocrinology andMetabolism, Daejeon Endo Internal Medicine, Daejeon, Republic of Korea

¹⁸. Research and Development Center, CYPHARMA, Daejeon, Republic of Korea

genekgh@kbsi.re.kr

Show less

History +

PDF

Cite this article

Download citation ▾

Minji Lee, Myung Jin Son, Sin-Hyoung Hong, Jae-Sung Ryu, Ji-Hyeon Min, Dong-Eon Lee, Ji Hoon Lee, Nam Doo Kim, Shi-Young Park, Darong Kim, Jeongmin Joo, Jisung Kwak, Kook Hwan Kim, Yong-Ho Lee, Byeong-Rak Keum, Hyun Seok Song, Youngae Jung, Koon Soon Kim, Gun-Hwa Kim. Discovery of a selective cytochrome P450 4A inhibitor for the treatment of metabolic dysfunction-associated fatty liver disease. Clinical and Translational Medicine, 2024, 14(10): e1816 DOI:10.1002/ctm2.1816

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.